MedCAC Supports Some PGx Test Regimens, But Calls For Overall Better Data

There is enough strong evidence to show that a select few pharmacogenomic (PGx) tests can be applied in a manner that positively affects patient outcomes, members of a CMS advisory panel concluded Jan. 27